Discontinuation report ABSTRAL
| Report ID | 56578 |
| Drug Identification Number | 02364174 |
| Brand name | ABSTRAL |
| Common or Proper name | FENTANYL |
| Company Name | PALADIN LABS INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | FENTANYL |
| Strength(s) | 100MCG |
| Dosage form(s) | TABLET |
| Route of administration | SUBLINGUAL |
| Packaging size | 10 Tabs |
| ATC code | N02AB |
| ATC description | OPIOIDS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2018-07-24 |
| Actual discontinuation date | 2018-07-24 |
| Remaining supply date | 2018-07-24 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
| Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2018-07-26 | French | Compare |
| v4 | 2018-07-26 | English | Compare |
| v3 | 2018-07-26 | French | Compare |
| v2 | 2018-07-26 | English | Compare |
| v1 | 2018-07-26 | English | Compare |
Showing 1 to 5 of 5